Article Information
History
- July 15, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Alex Adams1,*,†,
- Vipin Gupta1,2,*,
- Waled Mohsen1,3,*,
- Thomas P Chapman1,4,
- Deloshaan Subhaharan3,
- Pradeep Kakkadasam Ramaswamy3,
- Sudheer Kumar Vuyyuru5,
- Saurabh Kedia5,
- Colleen GC McGregor1,
- Tim Ambrose1,
- Bruce D George1,
- Rebecca Palmer1,
- Oliver Brain1,
- Alissa Walsh1,
- Vineet Ahuja5,
- Simon Travis1 and
- Jack Satsangi1,†
- 1Translational Gastroenterology Unit, NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
- 2Department Of Gastroenterology, Cardiff University Health Board, UK
- 3Digestive Diseases Unit, Gold Coast University Hospital, Queensland, Australia
- 4Department of Gastroenterology, Western Sussex NHS Foundation Trust
- 5Department of Gastroenterology, All India Institute of Medical Sciences (AIIMS), New Delhi, India
- ↵†Corresponding: John Radcliffe Hospital (Level 5), Headley Way, Headington, Oxford, OX3 9DU., Email: alex.adams{at}ndm.ox.ac.uk / jack.satsangi{at}ndm.ox.ac.uk
Posted July 15, 2021.
Optimising Early Management of Acute Severe Ulcerative Colitis in the Biologics Era: Admission Model for Intensification of Therapy in Acute Severe Colitis (ADMIT–ASC)
